Pneumocystis Prophylaxis
Pneumocystis Prophylaxis is a clinical pharmacological intervention classified as a preventive antimicrobial strategy that specifically targets the prevention of Pneumocystis jirovecii pneumonia in immunocompromised recipients of hematopoietic stem cell transplantation through targeted antimicrobial suppression during periods of sustained immune deficiency.
684
Publications
37.2K
Citations
3.5K
Authors
1.1K
Institutions
Publications per year
2017–2026
83
684
Successful Chemoprophylaxis for<i>Pneumocystis carinii</i>Pneumonitis
Walter T. Hughes, Shirley Kuhn, Subhash Chaudhary et al. · New England Journal of Medicine · 1977 · 693 citations
1–5 of 684
3.5K
St. Jude Children's Research Hospital, United States
20 publications · 1.9K citations
17
h-index
9
h-index
8
h-index
Indiana University – Purdue University Indianapolis, United States
7 publications · 657 citations
7
h-index
7
h-index
1–5 of 3.5K
1.1K

Johns Hopkins University
Baltimore, United States
26 h-index
83 publications
17.8K citations

St. Jude Children's Research Hospital
Memphis, United States
17 h-index
76 publications
8.8K citations

Centers for Disease Control and Prevention
Atlanta, United States
16 h-index
51 publications
2.4K citations
University of California, San Francisco
San Francisco, United States
15 h-index
45 publications
2.1K citations
Harvard University
Cambridge, United States
15 h-index
52 publications
9.1K citations

Johns Hopkins Medicine
Baltimore, United States
14 h-index
30 publications
2.7K citations
Assistance Publique – Hôpitaux de Paris
Paris, France
13 h-index
69 publications
2.6K citations
Indiana University – Purdue University Indianapolis
Indianapolis, United States
13 h-index
63 publications
4.1K citations
1–8 of 1.1K
Repository · 63 publications · 2.7K citations
31
h-index
CID · 35 publications · 2K citations
24
h-index
29 publications · 1.4K citations
22
h-index
AAC · 36 publications · 1.4K citations
21
h-index
NEJM · 19 publications · 5.8K citations
19
h-index
1–5